Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

FDA Approves Aficamten for Obstructive HCM

L.A. McKeown

December 29, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2025

Michael O'Riordan

June 30, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2024

Shelley Wood

April 03, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

Another Recall Warns of Unheralded Shutdowns With Cardiosave IABPs

Shelley Wood

March 31, 2023

News Daily News

Second Recall in Less Than 2 Months for Cardiosave IABPs

L.A. McKeown

March 17, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2022

Shelley Wood

October 03, 2022

News Daily News

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Michael O'Riordan

April 29, 2022

News Daily News

CDC Says Myocarditis ‘Likely’ Linked to mRNA Vaccines but Very Rare

Shelley Wood

June 24, 2021

News Daily News

FDA: Another Class I Recall for HeartWare VAD

Shelley Wood

April 16, 2021

News Daily News

FDA Warns of Premature Battery Depletion With Certain Medtronic Pacemakers

Michael O'Riordan

May 07, 2019

News Daily News

FDA Classifies Latest HeartWare VAD Recalls as Class I

Michael O'Riordan

October 24, 2016

News Daily News

St. Jude Medical Warns of Rapid, Unexpected, and Potentially Lethal Battery Depletions With ICDs, CRT-Ds

Shelley Wood

October 11, 2016

News Daily News

Current NSAID Use Linked to Increased Risk of Heart Failure, Large European Analysis Shows

Michael O'Riordan

September 30, 2016

News Daily News

FDA Warns of Class I Recall for HeartWare VAD Batteries

Michael O'Riordan

June 29, 2016

Advertisement

FDA Approves Aficamten for Obstructive HCM

TCTMD’s Top 10 Most Popular Stories for June 2025

TCTMD’s Top 10 Most Popular Stories for March 2024

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Another Recall Warns of Unheralded Shutdowns With Cardiosave IABPs

Second Recall in Less Than 2 Months for Cardiosave IABPs

TCTMD’s Top 10 Most Popular Stories for September 2022

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

CDC Says Myocarditis ‘Likely’ Linked to mRNA Vaccines but Very Rare

FDA: Another Class I Recall for HeartWare VAD

FDA Warns of Premature Battery Depletion With Certain Medtronic Pacemakers

FDA Classifies Latest HeartWare VAD Recalls as Class I

St. Jude Medical Warns of Rapid, Unexpected, and Potentially Lethal Battery Depletions With ICDs, CRT-Ds

Current NSAID Use Linked to Increased Risk of Heart Failure, Large European Analysis Shows

FDA Warns of Class I Recall for HeartWare VAD Batteries

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content